What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
This piece identifies funds with the highest management charges in the Dividend Aristocrats group and explains potential impact on performance.
26,423 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Investors chasing SpaceX-style wins without a private bet must weigh public players carefully. This guide compares AS...
Investors are weighing Tilray and Trulieve to find the better marijuana stock right now. This guide breaks down funda...
As AI fuels data-center growth, two infrastructure players stand out: Argan and Comfort Systems USA. This guide break...
A significant stake in Clearwater Analytics has sparked renewed interest in the company’s SaaS-driven investment acco...
Goldman Sachs sets COIN target at $235, signaling renewed confidence in Coinbase as crypto markets stabilize and inst...
GM and Ford are expanding into battery storage, boosting competition for Tesla and signaling a broader shift in how a...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A major institutional move signals a shift in risk tolerance and strategy. Learn what arcus capital scales back means...
The allure of in-person auditions can draw massive crowds—and big financial and safety risks. Cenat’s streamer univer...
When private materials move from a safe shelf to a digital vault, money and privacy collide. This article examines hu...
AMD’s latest earnings call highlights a rapid AI-led growth wave and a massive server CPU opportunity. Here are the f...